⦿ COVID-19
Vaccine Development, Recent Regulatory Changes, Affect on Clinical Sites
⦿ Data Management & Biostatistics
Clinical Data Strategy and Analytics, Artificial Intelligence in Clinical Research
⦿ Budgeting & Outsourcing
Mastering an Outsourcing Strategy, Managing Outsourced Clinical Trials
⦿ Decentralized Clinical Trials
Remote Clinical Trials, Virtual Clinical Visits, Challenges and Opportunities
⦿ Study Planning & Activation
Protocol Development, Global Site Selection, Feasibility and Site Management. Improving Study Start-Up and Performance in Site-Centered and Hybrid Trials.
Innovative and Adaptive Clinical Operations in Early Asset Development
In any clinical trial environment, process and acuity are paramount, but may also be rate-limiting to speed and innovation. While managing a primary focus on safety and compliance, early asset development allows an opportunity to develop innovative pathways to accelerate operational execution at the site and protocol level. In addition, asset congruency and big-picture portfolio planning increase these opportunities.
⦿ Clinical Supply
Data Technology for End-to-End Clinical Supply Management, Clinical Supply Management to Align Process, Products and Patients
⦿ Data & Tech Driven Clinical Trials
GDPR Regulations, Patient Privacy, Wearables for Trials, Emerging Technology Adoption Rates and their Impact on the 2025 Tech Roadmap
⦿ Biomarkers & Biospecimens
Biomarkers & Clinical Biomarkers Operations and Innovation, Clinical Biospecimens Technology and Outsourcing
⦿ Effective Monitoring & Implementation
Clinical Trial Forecasting, Budgeting and Contracting, Resource Management and Capacity Planning for Clinical Trials
⦿ Quality & Monitoring
Risk-Based Quality Management, Central and Remote Monitoring
⦿ Real World Evidence
Accessing and Generating RWD, Leveraging RWD for Clinical and Observational Research.
⦿ Tumor Model
Cells, tissues, or animals used to study the development and progression of cancer.